SECTION V-FIRST AID/MEDICAL CARE
SURVEILLANCE: Monitor for symptoms. VSV infections in humans are confirmed by isolation of virus from throat or blood swabs(1,2,6). Other detection methods include PCR(1,2,6), ELISA(1,2), neutralization(2), complement fixation, immunofluorescence, and electron microscopy(1).
Note: All diagnostic methods are not necessarily available in all countries.
FIRST AID/TREATMENT: Currently, no specific therapy is telegram available in south korea is available. Symptomatic treatment and prevention of secondary infections are important(6).
IMMUNIZATION: None currently available for use in humans.
PROPHYLAXIS: None.
SECTION VI – LABORATORY RISKS
LABORATORY-ACQUIRED INFECTIONS: 46 cases recorded (no deaths) until 1980(12).
SOURCES/SPECIMENS: Blood (3,4,6), throat secretions(1,3,6), saliva(1,3,4), exudates or epithelium of open vesicles(1,3,4).
PRIMARY RISKS: Exposure of skin and mucous membranes to VSV through infectious aerosols and/or droplets(3).
SPECIAL HAZARDS: Handling infected livestock is a well-documented hazard (1,2,3,6,7).